Insider Trading & Ownership - Inhibikase Therapeutics Inc. (IKT)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Inhibikase Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-08-16
Purchase		2022-08-16
4:25 pm		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		5,000$0.8$4,0005,335,433
(Direct)		View
2022-05-27
Purchase		2022-05-31
10:16 am		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		5,000$0.976$4,8805,330,433
(Direct)		View
2022-05-20
Purchase		2022-05-23
4:57 pm		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		10,000$0.6$6,0005,325,433
(Direct)		View
2022-05-19
Purchase		2022-05-23
4:54 pm		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		3,948$0.644$2,54348,091
(Direct)		View
2021-11-17
Purchase		2021-11-19
08:13 am		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		23,589$1.9737$46,5585,317,169
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-04-01
Option Award		2024-04-03
4:47 pm		N/A
2031-04-01		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		45,000$045,000
(Direct)		View
2024-04-01
Option Award		2024-04-02
5:14 pm		N/A
2031-04-01		Inhibikase Therapeutics Inc.IKTLees-Rolfe Garth
Chief Financial Officer		90,000$090,000
(Direct)		View

Ownership		2024-04-02
5:12 pm		N/A
2029-11-28		Inhibikase Therapeutics Inc.IKTLees-Rolfe Garth
Chief Financial Officer		0$05,834
(Direct)		View
2023-06-30
Option Award		2023-07-05
9:18 pm		N/A
2030-06-30		Inhibikase Therapeutics Inc.IKTBERMAN DENNIS N
Director		6,667$06,667
(Indirect)		View
2023-06-30
Option Award		2023-07-05
9:16 pm		N/A
2030-06-30		Inhibikase Therapeutics Inc.IKTDion Gisele
Director		6,667$06,667
(Direct)		View
2023-06-30
Option Award		2023-07-05
9:12 pm		N/A
2033-06-30		Inhibikase Therapeutics Inc.IKTGRINT PAUL C
Director		6,667$06,667
(Direct)		View
2023-06-30
Option Award		2023-07-05
9:11 pm		N/A
2030-06-30		Inhibikase Therapeutics Inc.IKTFreeman Roy Lester
Director		6,667$06,667
(Direct)		View
2023-03-01
Option Award		2023-03-03
5:00 pm		N/A
2030-03-01		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		210,000$0210,000
(Direct)		View
2023-03-01
Option Award		2023-03-03
5:00 pm		N/A
2023-03-01		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Cheif Financial Officer		90,000$0138,091
(Direct)		View
2022-09-01
Option Award		2022-09-06
5:08 pm		N/A
2032-09-01		Inhibikase Therapeutics Inc.IKTDion Gisele
Director		60,000$060,000
(Direct)		View
2022-06-24
Option Award		2022-06-28
9:00 pm		N/A
2029-06-24		Inhibikase Therapeutics Inc.IKTFreeman Roy Lester
Director		40,000$040,000
(Direct)		View
2022-06-24
Option Award		2022-06-28
9:00 pm		N/A
2029-06-24		Inhibikase Therapeutics Inc.IKTGRINT PAUL C
Director		40,000$040,000
(Direct)		View
2022-06-24
Option Award		2022-06-28
9:00 pm		N/A
2029-06-24		Inhibikase Therapeutics Inc.IKTO'Farrell Elizabeth G.
Director		40,000$040,000
(Direct)		View
2022-06-24
Option Award		2022-06-28
9:00 pm		N/A
2029-06-24		Inhibikase Therapeutics Inc.IKTBERMAN DENNIS N
Director		40,000$040,000
(Indirect)		View
2022-03-07
Option Award		2022-03-21
4:05 pm		N/A
2029-03-07		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		62,500$0106,643
(Direct)		View
2022-03-07
Option Award		2022-03-21
4:05 pm		N/A
2029-03-07		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		125,000$05,440,433
(Direct)		View
2022-03-07
Option Award		2022-03-09
8:22 pm		N/A
2029-03-07		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Cheif Financial Officer		62,500$0106,643
(Direct)		View
2022-03-07
Option Award		2022-03-09
8:21 pm		N/A
2029-03-07		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		125,000$05,440,433
(Direct)		View
2022-01-03
Exercise		2022-01-04
9:25 pm		N/A
N/A		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		21,853$2.025,315,433
(Direct)		View
2022-01-03
Exercise		2022-01-04
9:25 pm		N/A
2025-03-01		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		21,853$05,315,433
(Direct)		View
2021-08-17
Exercise		2021-08-19
07:46 am		N/A
N/A		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		21,853$2.025,293,580
(Direct)		View
2021-08-17
Exercise		2021-08-19
07:46 am		N/A
2023-06-01		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		21,853$05,293,580
(Direct)		View
2021-06-25
Option Award		2021-06-29
7:12 pm		2022-06-25
2028-06-25		Inhibikase Therapeutics Inc.IKTO'Farrell Elizabeth G.
Director		22,677$022,677
(Direct)		View
2021-06-25
Option Award		2021-06-29
7:11 pm		2022-06-25
2028-06-25		Inhibikase Therapeutics Inc.IKTGRINT PAUL C
Director		22,677$022,677
(Direct)		View
2021-06-25
Option Award		2021-06-29
7:10 pm		2022-06-25
2028-06-25		Inhibikase Therapeutics Inc.IKTFreeman Roy Lester
Director		22,677$022,677
(Direct)		View
2021-06-25
Option Award		2021-06-29
7:09 pm		2022-06-25
2028-06-25		Inhibikase Therapeutics Inc.IKTBERMAN DENNIS N
Director		22,677$022,677
(Indirect)		View
2021-05-14
Exercise		2021-05-18
5:46 pm		N/A
N/A		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		43,707$0.385,271,727
(Direct)		View
2021-05-14
Exercise		2021-05-18
5:46 pm		2011-06-01
2021-06-01		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		43,707$05,271,727
(Direct)		View
2021-05-14
Tax Withholding		2021-05-18
5:46 pm		N/A
N/A		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		16,918$4.595,271,727
(Direct)		View
2020-12-22
Option Award		2020-12-29
9:53 pm		2021-12-22
2030-12-22		Inhibikase Therapeutics Inc.IKTBERMAN DENNIS N
Director		6,825$06,825
(Direct)		View
2020-12-22
Option Award		2020-12-29
9:53 pm		2021-12-22
2030-12-22		Inhibikase Therapeutics Inc.IKTO'Farrell Elizabeth G.
Director		6,825$06,825
(Direct)		View
2020-12-22
Option Award		2020-12-29
9:53 pm		2021-12-22
2030-12-22		Inhibikase Therapeutics Inc.IKTGRINT PAUL C
Director		6,825$06,825
(Direct)		View
2020-12-22
Option Award		2020-12-29
9:52 pm		2021-12-22
2030-12-22		Inhibikase Therapeutics Inc.IKTFreeman Roy Lester
Director		6,825$06,825
(Direct)		View
2020-12-22
Option Award		2020-12-29
9:52 pm		N/A
2030-12-22		Inhibikase Therapeutics Inc.IKTWerner Milton H.
President and CEO
10% Owner		100,000$0100,000
(Direct)		View
2020-12-28
Conversion		2020-12-29
9:52 pm		N/A
N/A		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		44,143$10144,143
(Indirect)		View
2020-12-28
Conversion		2020-12-29
9:52 pm		2020-12-28
2021-12-31		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		441,432$0144,143
(Indirect)		View
2020-12-22
Option Award		2020-12-29
9:52 pm		N/A
2030-12-22		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		100,000$0144,143
(Direct)		View

Ownership		2020-12-22
8:42 pm		2020-08-25
2027-08-25		Inhibikase Therapeutics Inc.IKTFRATTAROLI JOSEPH
Chief Financial Officer		0$0171,854
(Indirect)		View

Ownership		2020-12-22
8:41 pm		2011-06-15
2031-06-15		Inhibikase Therapeutics Inc.IKTKalman Daniel
10% Owner		0$01,748,312
(Direct)		View

Ownership		2020-12-22
8:41 pm		2019-07-29
2026-07-28		Inhibikase Therapeutics Inc.IKTFreeman Roy Lester
Director		0$0131,122
(Direct)		View
Goto 0, 1, Next